Aorto-Iliac Thrombosis / Saddle Thrombus

Aorto-iliac thrombosis, commonly known as saddle thrombus in horses, is a vascular condition characterized by blood clot formation at the terminal aorta where it bifurcates into the iliac arteries that supply the hindlimbs. This strategic location explains the alternative name, as a clot sitting at the aortic bifurcation resembles a saddle straddling the vessel. The clot obstructs blood flow to one or both hindlimbs, causing inadequate perfusion during exercise when oxygen demands increase dramatically. This condition represents a significant cause of exercise-induced hindlimb lameness that resolves with rest.

Aorto-iliac thrombosis affects horses across various disciplines and breeds, though it appears more commonly in performance horses subjected to high-intensity athletic demands. The condition is relatively uncommon compared to musculoskeletal causes of hindlimb lameness, but its unique presentation pattern of exercise-induced symptoms that resolve with rest makes it recognizable to experienced equine practitioners. Historically, parasitic damage from Strongylus vulgaris larvae was a major cause, but modern deworming protocols have reduced this etiology while non-parasitic causes continue to occur.

The impact of aorto-iliac thrombosis on affected horses ranges from mild exercise limitation to severe performance impairment depending on the degree of vascular obstruction. Horses with partial occlusion may perform normally at low intensity but show dramatic symptoms during strenuous exercise. Complete obstruction of blood flow to a hindlimb causes severe clinical signs including acute lameness, weakness, and distress during exercise that can be alarming to witness. The condition is career-limiting for performance horses, as return to high-level athletics is often not possible even with treatment.

Early recognition and appropriate diagnosis of aorto-iliac thrombosis allows for implementation of treatment strategies that may improve outcomes. While complete resolution of established thrombi is challenging, medical management can prevent clot extension and may allow development of collateral circulation over time. Surgical intervention is available at specialized centers for selected cases. Understanding this condition helps owners and trainers recognize the characteristic symptom pattern and seek appropriate veterinary evaluation rather than pursuing treatment for presumed musculoskeletal problems.

The primary causes of aorto-iliac thrombosis in horses involve damage to the blood vessel wall that initiates clot formation, abnormalities in blood flow patterns that promote clot development, or alterations in blood composition that increase clotting tendency. Damage to the aortic or iliac endothelium may result from parasitic migration, particularly Strongylus vulgaris larvae that historically caused verminous arteritis during their migratory phase through the mesenteric arteries and aorta. While aggressive deworming programs have reduced parasitic causes, non-parasitic endothelial damage from other mechanisms continues to lead to thrombus formation.

Genetic predisposition to aorto-iliac thrombosis has not been clearly established, distinguishing this condition from inherited vascular diseases like aortic root disease in Friesians. However, individual variation in clotting tendency, vessel wall characteristics, and inflammatory responses may contribute to susceptibility. Some horses appear predisposed to thrombosis without identifiable cause, suggesting underlying factors not yet characterized. Research into equine coagulation disorders and vascular biology continues to explore potential hereditary contributions.

Environmental and management factors contributing to thrombus development include intensive athletic training that may cause repeated microtrauma to vessel walls from hemodynamic stress. Stall rest and reduced activity can allow blood stasis that promotes clot formation in predisposed individuals. Dehydration concentrates blood components and may increase clotting tendency. Concurrent illness, particularly conditions causing systemic inflammation, can trigger prothrombotic states. Parasitic exposure in horses with inadequate deworming programs remains a cause in some populations.

Risk factors for developing aorto-iliac thrombosis include advancing age with associated changes in vessel wall characteristics, history of parasitic infection with arterial damage, previous episodes of thrombosis indicating underlying prothrombotic tendency, and participation in high-intensity athletics. Horses with cardiovascular abnormalities affecting blood flow patterns may be predisposed. Concurrent conditions causing chronic inflammation, dehydration, or altered blood viscosity increase risk. Extended periods of immobility, such as prolonged stall rest for other conditions, can promote blood stasis and clot formation.

The pathophysiology of aorto-iliac thrombosis involves clot formation at the aortic bifurcation or in one or both iliac arteries. The clot may begin as a small mural thrombus and progressively enlarge, or may form acutely in response to significant vessel damage. As the thrombus grows, it increasingly obstructs blood flow to the hindlimbs. At rest, reduced flow may be adequate for tissue oxygen demands, but during exercise when hindlimb muscles require dramatically increased blood supply, the obstruction prevents adequate perfusion. This results in muscle ischemia with associated pain, weakness, and dysfunction that manifests as the characteristic exercise-induced lameness.

Early warning signs of aorto-iliac thrombosis may be subtle and easily attributed to other causes of poor performance. Horses may show mild exercise intolerance, reluctance to work at previously comfortable intensity levels, or vague hindlimb stiffness that improves with rest. Some horses display subtle changes in hindlimb movement quality during work, including shortened stride, reduced impulsion, or asymmetric movement that trainers notice but cannot specifically localize. The intermittent nature of symptoms, with horses appearing normal at rest and during light work, may delay investigation of the underlying cause.

Common symptoms of established aorto-iliac thrombosis become apparent during moderate to strenuous exercise. The hallmark presentation is hindlimb lameness or weakness that develops during exercise and resolves with rest, a pattern termed exercise-induced claudication. Affected horses may stumble, drag their toes, or show obvious limb weakness. The onset of symptoms typically correlates with exercise intensity and duration, with more demanding work producing earlier and more severe symptoms. Unilateral thrombus causes asymmetric signs affecting one limb more than the other.

Behavioral changes during exercise in horses with aorto-iliac thrombosis reflect the discomfort and dysfunction of ischemic muscles. Horses may become unwilling to continue work, stopping or slowing despite rider encouragement. Some display signs of distress or anxiety as symptoms develop. Profuse sweating, particularly over the hindquarters, occurs as ischemic muscles release metabolic byproducts. Horses may attempt to adopt postures that reduce hindlimb demands, including leaning forward or moving reluctantly behind. After stopping exercise, horses often stand quietly as symptoms gradually resolve.

Physical signs associated with aorto-iliac thrombosis include differences in limb temperature, with the affected limb feeling cooler due to reduced blood flow during or immediately after exercise. Reduced or absent digital pulses in the affected limb may be detected during symptomatic episodes. The hindlimb muscles may feel hard or cramped during ischemia. The affected limb may appear to fatigue more rapidly than the contralateral limb, with muscle trembling or obvious weakness. In severe cases, the limb may give way, causing the horse to nearly fall.

Symptom progression in aorto-iliac thrombosis varies depending on thrombus stability and development of collateral circulation. Some horses reach a stable plateau where symptoms remain consistent over time. Others experience progressive worsening as the thrombus enlarges and further restricts blood flow. Development of collateral blood vessel pathways around the obstruction may allow gradual improvement in some cases. Complete occlusion typically produces more severe and persistent symptoms than partial obstruction. Acute worsening can occur if the thrombus suddenly extends or embolizes to more distal vessels.

Emergency symptoms requiring immediate veterinary attention include acute severe hindlimb weakness or paralysis that does not resolve with rest, complete inability to support weight on one or both hindlimbs, signs of severe pain or distress, cold pulseless limb that fails to warm after cessation of exercise, and muscle swelling or hardness suggesting severe ischemic damage. These signs may indicate complete vascular occlusion with impending tissue necrosis, acute extension of the thrombus, or complications requiring urgent intervention. Horses showing such signs should cease all activity immediately and receive emergency veterinary evaluation.

Physical examination findings in horses with suspected aorto-iliac thrombosis focus on the characteristic pattern of exercise-induced symptoms. At rest, findings may be minimal or absent. Rectal palpation allows assessment of the terminal aorta and iliac arteries, potentially detecting a thrombus as an irregular, firm mass at the aortic bifurcation or reduced or absent arterial pulsation distal to an obstruction. Comparison of femoral artery pulses between limbs may reveal asymmetry. Post-exercise examination during a symptomatic episode may reveal limb temperature differences, altered pulse quality, and muscle changes not apparent at rest.

Diagnostic testing for aorto-iliac thrombosis relies heavily on imaging to visualize the vascular obstruction and assess its extent. Transrectal ultrasound examination provides direct visualization of the terminal aorta and iliac arteries, allowing identification of thrombus material, assessment of vessel wall changes, and Doppler evaluation of blood flow patterns. The degree of obstruction can be estimated based on residual vessel lumen. Nuclear scintigraphy using technetium-labeled red blood cells can map blood flow to the hindlimbs and identify perfusion deficits. Contrast angiography, though less commonly performed, provides detailed vascular imaging.

Advanced diagnostics may be employed for surgical planning or when initial testing is inconclusive. Computed tomography angiography offers three-dimensional vascular imaging with excellent detail of thrombus location and extent. Magnetic resonance angiography provides similar information with additional tissue characterization. Arterial blood gas analysis from samples drawn from femoral vessels can document reduced oxygen tension in the affected limb during exercise. Muscle biopsy from affected hindlimb muscles may reveal ischemic changes supporting the diagnosis. Coagulation testing may identify underlying prothrombotic conditions.

Differential diagnosis for exercise-induced hindlimb lameness that resolves with rest includes other conditions causing similar symptom patterns. Exertional rhabdomyolysis causes muscle pain and dysfunction during exercise but typically produces persistent symptoms after exercise cessation and markedly elevated muscle enzymes. Neurological conditions affecting hindlimb function may mimic vascular insufficiency. Sacroiliac dysfunction and other pelvic disorders cause exercise-related hindlimb problems. Cardiac conditions limiting exercise capacity can produce similar symptom patterns. The combination of characteristic history, rectal findings, and imaging typically allows definitive diagnosis of aorto-iliac thrombosis.

Emergency treatment for acute aorto-iliac thrombosis with severe symptoms focuses on pain management and prevention of further clot development. Anti-inflammatory medications provide analgesia and reduce inflammation associated with ischemia. Anticoagulant therapy using unfractionated or low molecular weight heparin prevents clot extension while allowing natural thrombolytic processes to work. Fluid therapy maintains hydration and blood flow characteristics. Strict rest minimizes oxygen demands of the affected limbs. Emergency situations with complete vascular occlusion and impending tissue necrosis may require urgent surgical intervention where available.

Medical management of chronic aorto-iliac thrombosis aims to prevent clot progression, support development of collateral circulation, and manage symptoms. Antiplatelet agents such as aspirin or clopidogrel reduce platelet aggregation and may help prevent thrombus extension. Pentoxifylline improves blood flow characteristics by increasing red blood cell deformability and reducing blood viscosity. Some practitioners use isoxsuprine as a vasodilator to improve peripheral circulation. Long-term anticoagulation may be considered for horses with ongoing prothrombotic risk. Medical therapy typically continues for extended periods, often indefinitely.

Surgical options for aorto-iliac thrombosis exist at specialized equine surgical centers and may be considered for selected cases. Thrombectomy involves surgical removal of the clot material, restoring blood flow if the procedure is successful. Aortoiliac bypass grafting has been reported, creating an alternative pathway for blood flow around the obstruction. Laser thrombolysis using catheter-delivered energy to dissolve clots represents an emerging technology. Surgical intervention requires specialized facilities, experienced surgeons, and appropriate case selection, as not all horses are suitable candidates. Success rates vary, and complications including reocclusion can occur.

Supportive care for horses with aorto-iliac thrombosis includes management adjustments to minimize symptom impact and maintain quality of life. Controlled exercise programs may help stimulate collateral circulation development while avoiding exercise intensities that trigger severe symptoms. Maintaining optimal body condition reduces workload on the compromised circulation. Addressing any underlying conditions that may have contributed to thrombus formation improves overall prognosis. Nutritional support with omega-3 fatty acids may provide anti-inflammatory and circulation benefits.

Rehabilitation and return to work following treatment for aorto-iliac thrombosis requires careful assessment of residual vascular compromise. Repeat imaging determines the degree of flow restoration or collateral development. Gradual introduction of exercise with careful monitoring for symptom recurrence guides activity progression. Many horses are unable to return to previous performance levels, and realistic expectations should be established. Some horses function acceptably for light work or pleasure riding despite residual perfusion deficits, while others remain limited to turnout only.

Treatment decisions for aorto-iliac thrombosis depend on multiple factors including thrombus extent, symptom severity, intended use of the horse, available treatment options, and financial considerations. Horses with mild symptoms and partial occlusion may be managed medically with activity modification. Severe cases in valuable performance horses may justify referral for surgical intervention. Horses intended for breeding rather than athletic use may function adequately with medical management alone. The chronic nature of the condition and the requirement for ongoing management should be understood when making treatment choices.

Recovery timeline for horses with aorto-iliac thrombosis varies substantially based on treatment approach, thrombus characteristics, and individual response. Medical management alone may require months for any improvement as collateral circulation slowly develops. Surgical intervention, if successful, can produce more rapid restoration of blood flow, though healing and rehabilitation still require weeks to months. Some horses reach stable improvement within three to six months, while others show gradual progress over a year or more. Complete resolution of symptoms is often not achieved, and horses may retain some degree of exercise limitation.

Post-treatment care and monitoring involve regular assessment of vascular status and symptom levels. Repeat ultrasonographic examination tracks changes in thrombus size and blood flow patterns. Exercise testing with careful observation identifies the current threshold for symptom development. Ongoing medical therapy continues as directed, with potential adjustments based on response. Owners should monitor for signs of symptom worsening that might indicate thrombus extension or loss of previously developed collateral circulation. Regular veterinary rechecks, typically every two to three months initially, guide management decisions.

Prognosis factors for horses with aorto-iliac thrombosis include the degree of vascular occlusion at diagnosis, response to initial treatment, development of collateral circulation, and intended use of the horse. Horses with partial occlusion and good collateral development may return to acceptable function for light work. Complete occlusion carries a poorer prognosis, particularly if collateral development is limited. Horses required for high-level athletic performance face unfavorable outlooks, as residual perfusion deficits typically preclude return to demanding competition. Horses for breeding or light pleasure use have more favorable prognoses.

Long-term soundness outlook for horses with aorto-iliac thrombosis generally involves acceptance of permanent limitations. Few horses return to previous performance levels following this diagnosis. Many can function for light riding, trail work, or pleasure activities that do not trigger symptom thresholds. Some remain pasture sound only, able to move about normally but unable to tolerate under-saddle work. Breeding careers may continue unaffected if horses can tolerate breeding activity without triggering symptoms. Ongoing management is typically required indefinitely, with continued vigilance for symptom changes.

Management practices to prevent aorto-iliac thrombosis center on maintaining vascular health and avoiding conditions that promote clot formation. Consistent, appropriate exercise programs maintain cardiovascular fitness without excessive stress. Avoiding prolonged immobility prevents blood stasis that can initiate thrombosis. Maintaining adequate hydration, particularly during hot weather and after exercise, preserves normal blood viscosity. Prompt treatment of conditions causing systemic inflammation reduces prothrombotic stimulus. Regular veterinary care allows detection of early vascular changes before clinical thrombosis develops.

Nutritional prevention strategies support cardiovascular health and may reduce clotting tendency. Omega-3 fatty acid supplementation from sources such as flax or fish oil provides anti-inflammatory effects and may reduce platelet aggregation. Adequate vitamin E intake supports vascular endothelial health. Avoiding obesity reduces overall cardiovascular strain. Maintaining appropriate electrolyte balance supports normal blood composition. While no specific nutritional protocol has been proven to prevent aorto-iliac thrombosis, overall cardiovascular wellness likely reduces risk.

Exercise and conditioning approaches that support vascular health involve gradual fitness development with appropriate recovery periods. Building cardiovascular fitness through progressive training programs improves blood flow capacity. Avoiding sudden increases in exercise intensity reduces vascular stress. Warm-up and cool-down periods support gradual blood flow changes. Monitoring horses during and after exercise for any signs of abnormal hindlimb function allows early detection of developing problems. Maintaining regular exercise rather than intermittent intense work provides consistent vascular conditioning.

Environmental factors affecting thrombosis risk include management of conditions that cause stress, dehydration, or inflammation. Ensuring constant access to fresh water prevents dehydration. Appropriate shelter and cooling during hot weather reduces heat stress and associated fluid losses. Minimizing transport stress through thoughtful travel planning and appropriate breaks reduces prothrombotic stimulus from prolonged standing and stress. Stable social groups reduce conflict-related stress. Clean environments minimize inflammatory challenges from respiratory or wound infections.

Parasite control remains relevant for aorto-iliac thrombosis prevention, particularly regarding Strongylus vulgaris. While modern deworming programs have dramatically reduced verminous arteritis, continued vigilance is warranted. Strategic deworming programs guided by fecal egg counts maintain effective parasite control. Properties with known parasite challenges may require more intensive management. New horses entering a property should be quarantined and evaluated before introduction to resident populations. Environmental management reducing pasture parasite burden supports overall parasite control efforts.

Daily management adjustments for horses diagnosed with aorto-iliac thrombosis focus on maintaining vascular health and avoiding symptom triggers. Consistent daily routines reduce stress that might affect cardiovascular function. Ensuring adequate water intake throughout the day maintains hydration. Regular low-intensity movement, such as turnout in appropriately sized paddocks, promotes circulation without excessive demands. Medication administration should follow veterinary instructions precisely, as antiplatelet and other agents require consistent dosing. Observing the horse during daily activities provides ongoing assessment of symptom status.

Housing and turnout considerations balance the benefits of movement against the risks of overexertion. Turnout allows voluntary movement that supports circulation and muscle health. Paddock size should be adequate for comfortable movement but not so large that horses run extensively. Companion selection matters, as avoiding horses that might trigger running or excitement reduces the risk of inadvertent overexertion. Terrain should be relatively flat to minimize cardiovascular demands from climbing. Access to shelter protects from weather extremes that stress the cardiovascular system.

Exercise modifications are essential for managing horses with aorto-iliac thrombosis. Activity intensity must remain below the threshold that triggers symptoms, which varies among individuals and requires careful determination through controlled exercise testing. Walking exercise is typically well tolerated and may be beneficial for maintaining fitness and circulation. Trotting may be acceptable for some horses in controlled conditions. Cantering and galloping are usually contraindicated due to high oxygen demands. Swimming, where available, may provide exercise with reduced cardiovascular demands compared to land-based work.

Monitoring and ongoing care requirements include regular observation for changes in symptom severity or pattern. Owners should know their horse's normal exercise tolerance and watch for any decrease suggesting disease progression. Limb temperature assessment after exercise provides information about perfusion adequacy. Watching for digital pulse changes helps track circulation status. Regular veterinary examinations with imaging allow objective assessment of vascular status over time. Any acute changes, particularly sudden worsening of symptoms or development of a cold limb, warrant immediate veterinary attention.

Quality of life and use considerations require realistic expectations about what affected horses can comfortably do. Many horses with aorto-iliac thrombosis can enjoy comfortable pasture existence with herd companions, representing acceptable quality of life despite athletic career limitations. Light trail riding may be possible for horses with mild disease if activity remains below symptom threshold. Breeding careers may continue for horses able to tolerate breeding activity. Horses unable to perform any meaningful activity without distress deserve honest evaluation of whether continued management serves their interests. Humane euthanasia remains an appropriate choice for horses with poor quality of life despite treatment.

No specific breed has been identified as having dramatically elevated risk for aorto-iliac thrombosis compared to others, distinguishing this condition from genetically influenced disorders like aortic root disease in Friesians. The condition occurs across the equine population without strong breed predilection. However, certain use categories may experience higher incidence due to management and athletic factors rather than genetic susceptibility. Performance horses subjected to intensive athletic training appear to be more commonly affected, possibly due to hemodynamic stresses on the vascular system or recognition bias from careful performance monitoring.

Racing Thoroughbreds and Standardbreds represent populations where aorto-iliac thrombosis may be recognized with some frequency, though this may reflect the high athletic demands and intensive veterinary scrutiny of racing populations rather than true breed susceptibility. Eventing horses and other sport horses experiencing high-intensity exercise may be similarly affected. Older horses across all breeds show increased incidence, reflecting age-related vascular changes rather than breed-specific factors. Historically, breeds managed on pastures with high parasite burdens experienced parasitic arteritis leading to thrombosis.

Genetic testing and breeding recommendations are not specifically applicable for aorto-iliac thrombosis given the absence of documented hereditary factors. Unlike conditions with clear genetic inheritance, aorto-iliac thrombosis does not require breeding restrictions or genetic screening. Focus instead should be on management practices that reduce risk factors for all horses. Horses that have experienced aorto-iliac thrombosis should be evaluated for any underlying conditions that might be heritable, but the thrombosis itself does not represent a breeding consideration. Maintaining healthy vascular systems through appropriate management benefits horses of all breeds.

Aorto-iliac thrombosis commonly occurs in the context of underlying conditions that promote clot formation or cause vessel wall damage. Verminous arteritis from Strongylus vulgaris migration historically represented the primary predisposing condition, with parasitic damage to vessel walls initiating thrombosis. While less common now, parasitic arterial damage still occurs in inadequately managed horses. Hypercoagulable states from various causes increase thrombosis risk systemically. Endothelial dysfunction from chronic inflammation, infection, or other vascular insults may predispose to thrombus formation. Identifying and addressing underlying conditions improves treatment success.

Conditions presenting with similar symptoms to aorto-iliac thrombosis require differentiation during diagnostic evaluation. Exertional rhabdomyolysis causes exercise-associated hindlimb dysfunction but typically produces persistent post-exercise symptoms and marked muscle enzyme elevation. Polysaccharide storage myopathy causes exercise intolerance with muscle cramping but shows characteristic muscle biopsy findings. Fibrotic myopathy affects hindlimb movement with a mechanical rather than exercise-dependent pattern. Sacroiliac disease causes hindlimb performance problems that may vary with exercise. Spinal cord compression produces neurological deficits that may worsen with exercise. Thorough examination and appropriate testing distinguish these conditions.

Potential complications of aorto-iliac thrombosis include progression to complete vascular occlusion with more severe clinical signs. Thromboembolism may occur if clot fragments break free and travel to smaller vessels, potentially causing acute limb ischemia. Ischemic damage to hindlimb muscles from chronic perfusion deficits can cause permanent weakness or fibrosis. Laminitis may occur as a complication of the systemic inflammatory response. Muscle necrosis from severe ischemia represents a grave complication requiring aggressive intervention. Ongoing thrombotic tendency may lead to additional clot formation in other vascular beds.